Ovid Therapeutics Inc. (OVID) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Join SI Premium – FREE
Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12).
For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- AI/ML Innovations plans $2M private placement on the CSE
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
